Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY and a 36.31% jump in the Nifty Pharma ...

Biocon’s stock jumped on December 24 after the United States Food and Drug Administration (USFDA) and the European Union ...

Shares of the biopharma major rose earlier today when it announced that its European partner, Zentiva, received a procedure ...

The rise in Biocon share price came after it announced that the company and its European partner, Zentiva, have received a ...

Biocon shares had gained earlier in the day after the company and its European partner Zentiva received a decentralised ...

Biocon and Zentiva receive EU approval for generic versions of Victoza (diabetes) and Saxenda (weight management). This marks ...

Biocon Ltd and Zentiva have secured decentralised procedure approval in the EU for Liraglutide, a complex formulation used ...

Biocon and Zentiva gain EU approval for generic Liraglutide, marking milestone in expanding complex generic medication ...

The European Medicines Agency’s (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars.

Biocon and Zentiva Gain EU Approval for Generic Liraglutide - Biocon Limited , in collaboration with its European partner ...

Bangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex ...

Bengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from ...